Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema

Docetaxel (DTX) is an effective commercial anticancer agent for chemotherapy in non–small cell lung cancer (NSCLC), breast cancer, gastric cancer, and prostate cancer, but its adverse effects including edema, neurotoxicity, and hair loss limit its application. To improve the chemotherapeutic efficac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Integr Cancer Ther
Hlavní autoři: Lim, Hyun-Kyung, Kim, Kyoung Mee, Jeong, Seong-Yun, Choi, Eun Kyung, Jung, Joohee
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2016
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739130/
https://ncbi.nlm.nih.gov/pubmed/27151585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735416645184
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky